Meclinas BV

Foundation date

30JUN2023

Sector

#Professional Services and Consulting

Subsector

Meclinas is a research unit, specialized in clinical studies for ambulatory drugs, psychiatric medicine, vaccinations, nutrition, cosmetics and medical devices

The center was officially established on 27 June 2023 by Ine Vercammen and Dr. Andreas Frans. Both childhood friends with a shared passion: the health of tomorrow!

For Meclinas, respect is paramount, both for the expectations of the clients of the studies, as well as for the well-being of the participants and the satisfaction of our staff.

This translates into quality and transparency which imbues us as a company as well as the working atmosphere.

Latest news

  • P95 Acquires Assign DMB, Expanding Data Management and Biostatistics Services

    Thursday September 5th 2024

  • reMYND appoints new CEO and Chairman to progress novel Alzheimer’s Disease program through clinical development

    Tuesday September 3rd 2024

  • Biotalys Receives Approval for Large-Scale Demonstration Trials of EVOCA in the Netherlands

    Monday September 2nd 2024